SIENNA BIOPHARM (SNNA) CFO Purchases $105,000.00 in Stock

SIENNA BIOPHARM (NASDAQ:SNNA) CFO Richard D. Peterson bought 7,000 shares of the stock in a transaction on Tuesday, August 1st. The shares were acquired at an average cost of $15.00 per share, with a total value of $105,000.00. Following the acquisition, the chief financial officer now directly owns 7,000 shares in the company, valued at approximately $105,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

SIENNA BIOPHARM (NASDAQ:SNNA) opened at 19.76 on Friday. SIENNA BIOPHARM has a one year low of $18.50 and a one year high of $21.20.

ILLEGAL ACTIVITY NOTICE: “SIENNA BIOPHARM (SNNA) CFO Purchases $105,000.00 in Stock” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.com-unik.info/2017/08/12/sienna-biopharmaceuticals-inc-snna-cfo-richard-d-peterson-buys-7000-shares-updated.html.

SIENNA BIOPHARM Company Profile

Sienna Biopharmaceuticals, Inc is a United States-based medical dermatology and aesthetics company. The Company focuses on developing targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients. Its research and clinical-stage candidates include programs, such as SNA-001, SNA-120 and SNA-125.

What are top analysts saying about SIENNA BIOPHARM? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SIENNA BIOPHARM and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit